Nevro Corp.

Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The Senza system is the only SCS system that delivers Nevro's proprietary HF10 therapy. The Nevro® Senza® SCS system received CE Mark in 2010, TGA Approval in 2011, FDA Approval in 2015, and is commercially available in Europe, Australia, and the United States.
Type
Public
HQ
Redwood City, US
Founded
2006
Size (employees)
518 (est)
Website
nevro.com
Nevro Corp. was founded in 2006 and is headquartered in Redwood City, US

Nevro Corp. Office Locations

Nevro Corp. has an office in Redwood City
Redwood City, US (HQ)
1800 Bridge Pkwy

Nevro Corp. Metrics

Nevro Corp. Financial Metrics

Revenue (2016)

$228.5 m

Revenue growth (2015-16), %

228%

Gross profit

$153.1 m

Gross profit margin (2016), %

67%

Net income (2016)

($31.8 m)

Market capitalization (28-Apr-2017)

$2.8 b

Closing share price (28-Apr-2017)

$93

Cash (31-Dec-2016)

$41.4 m
Nevro Corp.'s current market capitalization is $2.8 b.
Nevro Corp.'s revenue was reported to be $228.5 m in FY, 2016 which is a 228% increase from the previous period.
FY, 2014FY, 2015FY, 2016

Revenue

$32.6 m$69.6 m$228.5 m

Revenue growth, %

114%228%

Cost of goods sold

$11.3 m$28.1 m$75.4 m

Gross profit

$21.3 m$41.5 m$153.1 m

Gross profit Margin, %

65%60%67%

R&D expense

$19.8 m$21.4 m$33.7 m

Operating expense total

$49.6 m$103.9 m$176.2 m

EBIT

($28.3 m)($62.4 m)($23.1 m)

EBIT margin, %

(87%)(90%)(10%)

Interest expense

($16 k)($2.7 m)($6.4 m)

Interest income

($16 k)$575 k$1.7 m

Pre tax profit

($30.2 m)($66.3 m)($30.2 m)

Income tax expense

$478 k$1.2 m$1.6 m

Net Income

($30.7 m)($67.4 m)($31.8 m)
FY, 2014FY, 2015FY, 2016

Cash

$25.3 m$87 m$41.4 m

Accounts Receivable

$1.1 m

Inventories

$1.2 m

Current Assets

$201.1 m$282.6 m$420.3 m

PP&E

$647 k$5.8 m$7.1 m

Total Assets

$202.5 m$291.2 m$430.6 m

Accounts Payable

$7.1 m$1.8 m

Total Debt

$39 m$39.5 m

Current Liabilities

$10.8 m$36.4 m$42.2 m

Additional Paid-in Capital

$293.9 m$424.1 m$470.9 m

Retained Earnings

($122 m)($189.4 m)($221.2 m)

Total Equity

$172.1 m$234.6 m$249 m

Debt to Equity Ratio

0.2 x0.2 x

Debt to Assets Ratio

0.2 x0.1 x

Financial Leverage

1.2 x1.2 x1.7 x
FY, 2014FY, 2015FY, 2016

Net Income

($30.7 m)($67.4 m)($31.8 m)

Depreciation and Amortization

$96 k$614 k$1.7 m

Accounts Payable

$933 k$1.3 m

Cash From Operating Activities

($31.1 m)($100.4 m)($58.5 m)

Purchases of PP&E

($625 k)($5 m)($3.4 m)

Cash From Investing Activities

($131.7 m)

Long-term Borrowings

($19.5 m)

Cash From Financing Activities

$152.1 m$122.8 m$145.2 m

Interest Paid

$2.3 m$2.5 m

Income Taxes Paid

$670 k$492 k

Nevro Corp. Operating Metrics

FY, 2016

Patents Issued

132

Patents Pending

101

Trademarks

16

Nevro Corp. Market Value History

Nevro Corp. Online Presence

Nevro Corp. Company Life

You may also be interested in